Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-29

Clinical Trial Update: To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the relative bioavailability of azithromycin 600 mg tablets under fed conditions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin 600 mg tablet (Azithromycin)

Snippet

Sponsor: Sandoz | Conditions: Infection | Phase 1 | Status: COMPLETED